Strong Points

  • 40 years of experience (1977-2017), 536,000 tests until today
  • Center specialized in rare genetic disorders
  • Genetic counseling for genetic disorders and teratogenic agents (>7,500 cases)
  • Genetic counseling before and after application of genetic testing
  • Close collaboration with the referring physician
  • Large experience in prenatal chromosomal diagnosis (>95.000 cases)
  • First international clinical application of the extended prenatal panel (>4.500 cases)
  • Routine application of molecular karyotype-aCGH in prenatal diagnosis (>7.000 cases)
  • In-depth analysis of products of abortion (>6.600 cases)
  • Longstanding experience in cytogenetics of leukemias (>11.000 cases)
  • In-depth analysis of cases utilizing molecular cytogenetic techniques (FISH)
  • Leaders in preimplantation genetic diagnosis for rare gene disorders (>400 cases)
  • Pioneering applications of preimplantation genetic diagnosis for HLA-matching, first international cases
  • First clinical postnatal arrayCGH applications in Greece
  • Broad spectrum of diagnostic tests for molecular pathology
  • Introduction of the ‘dry test’ for prenatal biochemical marker screening
  • Pioneering applications of whole exome sequencing in Greece
  • Extended testing for cystic fibrosis with the incorporation of Greek mutations
  • Comprehensive clinical and laboratory testing for mental retardation
  • Broad spectrum of genetic tests for syndromic skeletal dysplasias
  • Application of genetic linkage analysis for sex-linked or other disorders
  • Large experience and internationally recognized know-how in genetic identity testing (>5.500 cases)
  • Comprehensive sperm analysis by flow cytometry
  • Continuous upgrading of laboratory equipment
  • Highly trained and experienced scientific personnel
  • Emphasis in research and development and in applied genetic research
  • Independently funded research in diagnostic genetics
  • Constant participation in international and national meetings
  • Publications in established international journals
  • Continuous and successful participation in external quality control schemes(EMQN-CF Network, CEQAS, etc.)
  • Quality management system (EN ISO 9001:2008) certified by ESYD
  • Excellent secretarial support
  • Emphasis in printed and digital information material for the general public and physicians
  • Highly competitive prices, below international average
  • Constant profitability, ensuring continuous and healthy growth over the yearsν
  • Social responsibility and contribution through provision of pro bono testing to vulnerable groups
  • Development of international scientific collaborations
  • Substantial and systematic educational work